Physiological roles of the GIP receptor in murine brown adipose tissue

被引:48
作者
Beaudry, Jacqueline L. [1 ]
Kaur, Kiran D. [1 ]
Varin, Elodie M. [1 ]
Baggio, Laurie L. [1 ]
Cao, Xiemin [1 ]
Mulvihill, Erin E. [1 ,3 ]
Bates, Holly E. [1 ,4 ]
Campbell, Jonathan E. [1 ,5 ]
Drucker, Daniel J. [1 ,2 ]
机构
[1] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave,TCP5-1004, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Ottawa, Heart Inst, 40 Ruskin St,H-3228A, Ottawa, ON KIY 4W7, Canada
[4] Trent Univ, Biol, 2140 East Bank Dr, Peterborough, ON K9L 1Z8, Canada
[5] Duke Mol Physiol Inst, 49-102,300 N Duke St, Durham, NC 27701 USA
基金
加拿大健康研究院;
关键词
Glucose-dependent insulinotropic polypeptide receptor; Brown adipose tissue; Thermogenesis; Energy expenditure; Obesity; Lipid metabolism; DEPENDENT INSULINOTROPIC POLYPEPTIDE; HIGH-FAT DIET; BODY-WEIGHT; COMMON VARIANTS; RESISTANCE; OBESITY; EXPRESSION; PHARMACOLOGY; INHIBITION; SECRETION;
D O I
10.1016/j.molmet.2019.08.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Glucose-dependent insulinotropic polypeptide (GIP) is secreted from the gut in response to nutrient ingestion and promotes meal-dependent insulin secretion and lipid metabolism. Loss or attenuation of GIP receptor (GIPR) action leads to resistance to diet-induced obesity through incompletely understood mechanisms. The GIPR is expressed in white adipose tissue; however, its putative role in brown adipose tissue (BAT) has not been explored. Methods: We investigated the role of the GIPR in BAT cells in vitro and in BAT-specific (Gipr(BAT-/-)) knockout mice with selective elimination of the Gipr within the Myf5(+) expression domain. We analyzed body weight, adiposity, glucose homeostasis, insulin and lipid tolerance, energy expenditure, food intake, body temperature, and iBAT oxygen consumption ex vivo. High-fat diet (HFD)-fed Gipr(BAT-/-) mice were studied at room temperature (21 degrees C), 4 degrees C, and 30 degrees C ambient temperatures. Results: The mouse Gipr gene is expressed in BAT, and GIP directly increased Il6 mRNA and IL-6 secretion in BAT cells. Additionally, levels of thermogenic, lipid and inflammation mRNA transcripts were altered in BAT cells transfected with Gipr siRNA. Body weight gain, energy expenditure, and glucose and insulin tolerance were normal in HFD-fed Gipr(BAT-/-) mice housed at room temperature. However, Gipr(BAT-/-) mice exhibited higher body temperatures during an acute cold challenge and a lower respiratory exchange ratio and impaired lipid tolerance at 21 degrees C. In contrast, body weight was lower and iBAT oxygen consumption was higher in HFD-fed mice housed at 4 degrees C but not at 30 degrees C. Conclusions: The BAT GIPR is linked to the control of metabolic gene expression, fuel utilization, and oxygen consumption. However, the selective loss of the GIPR within BAT is insufficient to recapitulate the findings of decreased weight gain and resistance to obesity arising in experimental models with systemic disruption of GIP action. (C) 2019 The Authors. Published by Elsevier GmbH.
引用
收藏
页码:14 / 25
页数:12
相关论文
共 41 条
[1]   Gipr Is Essential for Adrenocortical Steroidogenesis, However, Corticosterone Deficiency Does Not Mediate the Favorable Metabolic Phenotype of Gipr-/- Mice [J].
Bates, Holly E. ;
Campbell, Jonathan E. ;
Ussher, John R. ;
Baggio, Laurie L. ;
Maida, Adriano ;
Seino, Yutaka ;
Drucker, Daniel J. .
DIABETES, 2012, 61 (01) :40-48
[2]   Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study [J].
Bergmann, Natasha C. ;
Lund, Asger ;
Gasbjerg, Lwrke S. ;
Meessen, Emma C. E. ;
Andersen, Maria M. ;
Bergmann, Sigrid ;
Hartmann, Bolette ;
Holst, Jens J. ;
Jessen, Lene ;
Christensen, Mikkel B. ;
Vilsboll, Tina ;
Knop, Filip K. .
DIABETOLOGIA, 2019, 62 (04) :665-675
[3]   Gastric inhibitory polypeptide immunoneutralization attenuates development of obesity in mice [J].
Boylan, Michael O. ;
Glazebrook, Patricia A. ;
Tatalovic, Milos ;
Wolfe, M. Michael .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2015, 309 (12) :E1008-E1018
[4]  
Campbell J. E., 2016, NAT MED, P2284
[5]   Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action [J].
Campbell, Jonathan E. ;
Drucker, Daniel J. .
CELL METABOLISM, 2013, 17 (06) :819-837
[6]   LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept [J].
Coskun, Tamer ;
Sloop, Kyle W. ;
Loghin, Corina ;
Alsina-Fernandez, Jorge ;
Urva, Shweta ;
Bokvist, Krister B. ;
Cui, Xuewei ;
Briere, Daniel A. ;
Cabrera, Over ;
Roell, William C. ;
Kuchibhotla, Uma ;
Moyers, Julie S. ;
Benson, Charles T. ;
Gimeno, Ruth E. ;
D'Alessio, David A. ;
Haupt, Axel .
MOLECULAR METABOLISM, 2018, 18 :3-14
[7]   Therapeutic strategies based on glucagon-like peptide 1 [J].
Deacon, CF .
DIABETES, 2004, 53 (09) :2181-2189
[8]   Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men [J].
Dekker, Mark J. ;
Graham, Terry E. ;
Ooi, T. C. ;
Robinson, Lindsay E. .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2010, 21 (10) :983-990
[9]   The role of gut hormones in glucose homeostasis [J].
Drucker, Daniel J. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (01) :24-32
[10]   Discovery, characterization, and clinical development of the glucagon-like peptides [J].
Drucker, Daniel J. ;
Habener, Joel F. ;
Holst, Jens Juul .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (12) :4217-4227